InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Tousignant Jennifer, Directeur Juridique. Officer active across 1 company, notably Viridian Therapeutics, Inc.\DE. In total, 6 filings have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €361k. History available since 31 December 2025. The latest transaction was disclosed on 19 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Tousignant Jennifer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
4,212 股@ US$24.50Common StockSEC:0001193125-26-359636:0
10,000 股@ US$14.41Common StockSEC:0001193125-26-359636:1
10,000 股@ US$24.50Common StockSEC:0001193125-26-359636:2
1,675 股@ US$30.190.0019% mcap50.0% 占其流量Common StockSEC:0001193125-26-099008:0
5,169 股Common StockSEC:0001193125-26-092074:0
2,272 股@ US$31.1658.2% 占其流量Common StockSEC:0001193125-26-001097:0
6 条申报中的 6 条
About Tousignant Jennifer
Jennifer Tousignant is the Chief Legal Officer at Viridian Therapeutics, Inc. She is responsible for managing the legal affairs and regulatory compliance of the company. With a strong background in law, Jennifer Tousignant contributes to the overall strategy and regulatory compliance of Viridian Therapeutics, Inc.
